Questions people ask about tesamorelin
Each answer tells you who was studied, what happened, and what the study cannot promise.
What did researchers make tesamorelin to do?
Tesamorelin’s makers began with a 44-amino-acid hormone, a chain of small protein parts. A chemical change helped the drug last longer [7]. The change keeps tesamorelin intact until it reaches the pea-size gland under the brain. In 2010, the FDA approved tesamorelin only for extra deep fat after HIV care changed fat storage [5]. Other uses remain outside that approval.
What did tesamorelin change in the main trial?
A 26-week Phase 3 study—a late study meant to check benefit and harm—followed 412 people in HIV care. With 2 milligrams each day, deep fat shrank 15.2%. The placebo group got a no-drug shot, and its fat rose 5.0% [1]. Blood fat fell. IGF-1, a liver-made growth protein, rose 81%.
Growth hormone still came in brief bursts [4]. Your health may not match the health of those patients.
How does tesamorelin tell the growth gland to act?
Tesamorelin makes the brain’s growth gland release growth hormone [4]. The liver makes the growth protein IGF-1. In healthy men, IGF-1 rose 181 micrograms per liter [4]. A microgram is one part of a gram split a million ways. Without a starting level, that rise can’t show how the men felt.
Both help use stored fat. Firm proof covers fat trouble caused by HIV care.
Does tesamorelin supply growth hormone?
No. Tesamorelin copies a brain hormone. The copied hormone tells the growth gland under the brain when growth hormone should enter your blood. Many blood samples showed the level rising and falling in bursts [10]. The study’s math confirmed those bursts; it didn’t show a new benefit. Tesamorelin isn’t growth hormone.
Does tesamorelin work like a GLP-1 weight drug?
No. GLP-1 is the short name for a gut hormone that affects hunger, blood sugar, and how fast food leaves your stomach. Weight drugs copy that gut hormone. Tesamorelin prompts the pea-size gland under the brain to send growth hormone out in short rises [4].
The drugs act through different parts of your body.
Which tesamorelin use has FDA approval?
The FDA approved tesamorelin in 2010 for one use [5]. It may reduce extra deep belly fat in people whose HIV drugs changed where their bodies store fat.
FDA approval does not cover another kind of fat problem. That narrow wording tells you where the proof and approval end.
Could tesamorelin help my deep belly fat?
In people whose HIV care changed fat storage, 2 milligrams a day of tesamorelin cut deep belly fat 15.2% at 26 weeks [1]. In 2026, reviewers combined results from five trials. Their overall answer also showed less deep belly fat [14].
A large trial hasn’t shown the same benefit for you if you don’t have the deep-fat problem caused by HIV care.
Which kind of belly fat did tesamorelin reduce?
Tesamorelin reduced deep belly fat while mostly sparing the layer under the skin. The usual height-and-weight number changed little. In 2014, one scan showed 42 fewer square centimeters of deep fat [3]. That figure describes an area on the scan, not an amount taken out of someone.
The adults studied had HIV and the related fat problem. Your result could differ.
When did tesamorelin change deep belly fat?
The first large study reported that deep abdominal fat had fallen at 26 weeks [1]. A second study found the loss still present at 52 weeks, with the fat 18% below its starting amount [2].
Those dates came from people receiving HIV care. They don’t set a timetable for your body. Once treatment ended, deep fat began returning.
What has tesamorelin proved about fat loss without HIV?
The main fat-loss trials followed people receiving HIV care. One small test with healthy men checked changes in growth hormones [4]. It didn’t test fat loss as a health result.
Without a large trial, you can’t assume the fat finding applies to people without HIV. This use also falls outside the drug label.
What did tesamorelin do to fatty liver in the HIV study?
A 6-month trial followed people receiving HIV care. Liver fat fell 2.9% more with tesamorelin than with the comparison treatment [3]. In 2026, reviewers combined five trials and found 4.28% less liver fat overall [14].
Fatty-liver treatment is still being studied and isn’t an approved use. If your liver problem has another cause, these figures may not fit you.
How did tesamorelin affect the liver and liver safety?
Growth hormone and IGF-1 rose while both liver fat and deep abdominal fat went down. Liver fat dropped 2.9% in the HIV study group [3].
A government review gave tesamorelin a score of E. That means clear liver injury looked unlikely. Liver blood tests didn’t begin climbing, and no trial injury was tied to the drug [5].
How strong is the tesamorelin liver-fat result?
In adults receiving HIV care who also had fatty liver, 2 milligrams a day of tesamorelin cut liver fat 2.9% more than placebo in 2014 [3]. In the 2026 review, researchers combined five trials and found 4.28% less liver fat overall [14].
Those findings apply to adults receiving HIV care. They don’t settle the question for other people.
Why does tesamorelin last longer than sermorelin?
Tesamorelin keeps the full natural hormone chain and adds a small shield against an enzyme’s cut. Sermorelin uses a shorter chain without that shield [7].
A medical review also covers Phase 3, a late study meant to check benefit and harm. Tesamorelin reduced deep belly fat in people receiving HIV care [7]. Longer blood time may not be the reason.
Do studies show tesamorelin is better than sermorelin?
No direct study has compared the two drugs. Tesamorelin has two key Phase 3 trials—late studies that checked the main result and watched for harm—and a 2026 review for the deep-fat problem caused by HIV care [1][14]. Sermorelin has no matching deep-fat trials.
Tesamorelin has stronger proof for one narrow use. That doesn’t prove it is better for every goal.
Have people taken tesamorelin and sermorelin together in a trial?
No published human trial has tested tesamorelin with sermorelin, ipamorelin, or CJC-1295. The main trials used tesamorelin alone [1]. Ipamorelin copies a stomach hormone. The other drugs copy a brain hormone, and the two kinds reach the growth gland by different routes [8].
That difference can’t tell you whether a mix helps or harms. No good human trial has checked a mix.
What does tesamorelin half-life mean?
Blood samples gave a calculated rate of 1,060 liters per hour [6]. No such liquid moved through a person; the math label only shows that the drug level fell very fast. Other sources put the half-life—the time for the level to fall by half—at about 26-38 minutes.
IGF-1, a liver-made growth protein, stayed raised after tesamorelin had cleared [4].
How long does tesamorelin stay in your blood?
Tesamorelin left blood quickly. The calculated 1,060 liters per hour rate only means the level fell very fast; it does not measure liquid moving through your body. By day 14, blood tests showed the body absorbed about 13% more from each dose than on day 1 [6].
Growth hormone and IGF-1 lasted longer. That helps explain the daily shot studied [4].
Which tesamorelin side effects appeared in trials?
Trials found sore or red shot sites, headache, sore joints, and fluid buildup. IGF-1, a growth-related blood protein, also rose as expected [4]. During the 52-week program, blood-sugar changes stayed too slight to change care [2].
A government review gave tesamorelin a score of E, meaning clear liver injury looked unlikely [5].
Why can tesamorelin cause fluid buildup?
Higher growth hormone can make body tissues hold fluid. Tesamorelin raises growth hormone made inside your body and IGF-1, a growth-related liver protein, so swelling can follow [4].
During the 52-week study, researchers tied no serious harm to the drug [2]. That finding can’t judge swelling in your own case.
What did tesamorelin do to diabetes risk and blood sugar?
A study of 13 healthy men found no clear shift in blood sugar after a fast or in their response to insulin [4]. A 52-week HIV study also saw no shift that would alter care [2].
Growth hormone can still push sugar upward. A separate diabetes study used the hemoglobin test that shows average blood sugar over a few months. That test did not clearly change. Your own blood tests may give your doctor a different answer.
Who must avoid tesamorelin?
Tesamorelin has to be avoided while cancer is active. The drug raises growth hormone and IGF-1, a liver-made growth protein. People whose blood sugar is hard to control may need blood tests [5]. The drug is also banned in sport [15].
A product marked for lab work can’t be injected into a person. Prescribing tesamorelin, whether the approved medicine or a compounded preparation, calls for a licensed clinician’s assessment of your health history; a request can be refused.